Literature DB >> 8634440

Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.

A Madani1, V Choukroun, J Soulier, V Cacheux, J F Claisse, F Valensi, S Daliphard, B Cazin, V Levy, V Leblond, M T Daniel, F Sigaux, M H Stern.   

Abstract

T-cell prolymphocytic leukemia (T-PLL), a rare form of mature T-cell leukemias, and ataxia telangiectasia clonal proliferation, a related condition occurring in patients suffering from ataxia telangiectasia, have been associated to translocations involving the 14q32.1 or Xq28 regions, where are located the TCL1 and MTCP1 putative oncogenes, respectively. The MTCP1 gene is involved in the t(X;14)(q28;q11) translocation associated with these T-cell proliferations. Alternative splicing generates type A and B transcripts that potentially encode two entirely distinct proteins; type A transcripts code for a small mitochondrial protein, p8MTCP1, and type B transcripts, containing an additional open reading frame, may code for 107 amino-acid protein, p13MTCP1. The recently cloned TCL1 gene, also involved in translocations and inversions associated with T-cell proliferations, codes for a 14-kD protein that displays significant homology with p13MTCP1. We have generated rabbit antisera against this putative p13MTCP1 protein and screened for expression of p13MTCP1 normal lymphoid tissues and 33 cases of immature and mature lymphoid T-cell proliferations using a sensitive Western blot assay. We also investigated the MTCP1 locus configuration by Southern blot analysis. The p13MTCP1 protein was detected in the three T-cell proliferations with MTCP1 rearrangements because of t(X;14) translocations, but neither in normal resting and activated lymphocytes nor in the other T-cell leukemias. Our data support the hypothesis that p13MTCP1 and p14TCL1 form a new protein family that plays a key role in the pathogenesis of T-PLL and related conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8634440

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

Authors:  Eugenio Gaudio; Riccardo Spizzo; Francesco Paduano; Zhenghua Luo; Alexey Efanov; Alexey Palamarchuk; Amanda S Leber; Mohamed Kaou; Nicola Zanesi; Arianna Bottoni; Stefan Costinean; Laura Z Rassenti; Tatsuya Nakamura; Thomas J Kipps; Rami I Aqeilan; Yuri Pekarsky; Francesco Trapasso; Carlo M Croce
Journal:  Blood       Date:  2011-11-07       Impact factor: 22.113

Review 3.  T-cell prolymphocytic leukemia.

Authors:  Claire E Dearden
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

4.  Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Authors:  Ke Lan; Masanao Murakami; Tathagata Choudhuri; Donald E Tsai; Stephen J Schuster; Mariusz A Wasik; Erle S Robertson
Journal:  J Clin Virol       Date:  2008-09-14       Impact factor: 3.168

5.  Refined solution structure and backbone dynamics of 15N-labeled C12A-p8MTCP1 studied by NMR relaxation.

Authors:  P Barthe; L Chiche; N Declerck; M A Delsuc; J F Lefèvre; T Malliavin; J Mispelter; M H Stern; J M Lhoste; C Roumestand
Journal:  J Biomol NMR       Date:  1999-12       Impact factor: 2.835

6.  Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas.

Authors:  Eugenio Gaudio; Francesco Paduano; Apollinaire Ngankeu; Francesca Lovat; Muller Fabbri; Hui-Lung Sun; Pierluigi Gasparini; Alexey Efanov; Yong Peng; Nicola Zanesi; Mohammed A Shuaib; Laura Z Rassenti; Thomas J Kipps; Chenglong Li; Rami I Aqeilan; Gregory B Lesinski; Francesco Trapasso; Carlo M Croce
Journal:  Blood       Date:  2012-11-15       Impact factor: 22.113

7.  Backbone dynamics and solution structure refinement of the 15N-labeled human oncogenic protein p13MTCP1: comparison with X-ray data.

Authors:  L Guignard; A Padilla; J Mispelter; Y S Yang; M H Stern; J M Lhoste; C Roumestand
Journal:  J Biomol NMR       Date:  2000-07       Impact factor: 2.835

8.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

9.  Solution structure of the recombinant human oncoprotein p13MTCP1.

Authors:  Y S Yang; L Guignard; A Padilla; F Hoh; M P Strub; M H Stern; J M Lhoste; C Roumestand
Journal:  J Biomol NMR       Date:  1998-04       Impact factor: 2.835

10.  Solution structure and backbone dynamics of the pleckstrin homology domain of the human protein kinase B (PKB/Akt). Interaction with inositol phosphates.

Authors:  Daniel Auguin; Philippe Barthe; Marie-Thérèse Augé-Sénégas; Marc-Henri Stern; Masayuki Noguchi; Christian Roumestand
Journal:  J Biomol NMR       Date:  2004-02       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.